Fatmata Boyie Bah

Fatmata Bah practices at MUSC Health West Ashley Medical Pavilion in Mount Pleasant, South Carolina.

Fatmata Bah's NPI, 1477115392, was assigned on July 1, 2019. Fatmata Bah holds South Carolina license LL82953.

Fatmata Bah's primary practice is MUSC Health West Ashley Medical Pavilion, at 1600 Midtown Ave, Mount Pleasant, SC 29464 in Charleston County. The practice phone is (843) 792-1414.

Fatmata Bah's primary practice is MUSC Health West Ashley Medical Pavilion in Mount Pleasant, South Carolina. Fatmata Bah is also affiliated with MUSC Health University Medical Center. The medical group on file is MUSC Health Primary Care (Citadel Mall). Dmand AI also links Fatmata Bah to 1 more hospital, 2 home health agencies and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Fatmata Bah practices, 5 sites in all. Vendor and product names are available with a free account.

Internal medicine is Fatmata Bah's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Fatmata Bah is licensed in South Carolina.

CMS data shows 481 Medicare services from Fatmata Bah across 9 procedure codes in 2024, for 201 Medicare patients. Medicare paid $28,415 for them. Every service was in an office.

CMS counts 201 Medicare patients who saw Fatmata Bah in 2024. The largest group is 65 to 74, with 108 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 5% are also on Medicaid. Their average risk score is 0.98, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Fatmata Bah's median patient age at 61, with 74% women.

In 2024, Fatmata Bah wrote 2,126 Medicare Part D claims for 313 patients. 84% of them were for generic drugs. CMS names the drug for 1,463 of them, across 53 drugs with 11 or more claims each, at $104,091 in total drug cost. In 2022, CMS named 51 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Fatmata Bah for performance year 2024, reported as part of a group. Fatmata Bah accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Fatmata Bah as offering telehealth.

Dmand AI links 5 papers to Fatmata Bah, published from 2020 to 2025. The most frequent topics are Induced Pluripotent Stem Cells and Neurons. Fatmata Bah's most frequent co-authors are David A. Bennett, MD and Eric Matthew Morrow, MD, PhD.

CMS Open Payments shows 1 general payment to Fatmata Bah from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. Eli Lilly and Company paid the most, $23.